Poseida Sinks On Prostate Cancer CAR-T Clinical Hold

The Newly Public Company’s Stock Closed Down 30%

 
• By Mandy Jackson
  
stopping the Dominio effect
A Phase I trial of P-PSMA-101 was stopped after a prostate cancer patient died
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D